BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
14 results:

  • 1. [Efficacy of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei].
    Lei ZY; Ding BH; Wu QY; Luo JL; Li Z; Wang T; Wang YS; Chen YX; Huang LF; He JF; Yang XS; Guan TP; Ruan Q; Wang JH; Tang HS; Wang J; Cui SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1179-1186. PubMed ID: 38110280
    [No Abstract]    [Full Text] [Related]  

  • 2. A novel hif2a mutation causes dyslipidemia and promotes hepatic lipid accumulation.
    Gao F; Yao Q; Zhu J; Chen W; Feng X; Feng B; Wu J; Pacak K; Rosenblum J; Yu J; Zhuang Z; Cao H; Li L
    Pharmacol Res; 2023 Aug; 194():106851. PubMed ID: 37453673
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Laparoscopic modular extended right posterior sectionectomy for hepatocellular carcinoma guided by projection plane extension from the right hepatic vein.
    Lin J; Fang C; Yang J
    J Gastrointest Surg; 2023 Jul; 27(7):1494-1495. PubMed ID: 36932306
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer.
    Pak S; Jung KW; Park EH; Ko YH; Won YJ; Joung JY
    Investig Clin Urol; 2022 Mar; 63(2):175-183. PubMed ID: 35244991
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Modulation of sulfur assimilation metabolic toxicity overcomes anemia and hemochromatosis in mice.
    Hale AT; Brown RE; Luka Z; Hudson BH; Matta P; Williams CS; York JD
    Adv Biol Regul; 2020 May; 76():100694. PubMed ID: 32019729
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
    Tsai WC; Kung PT; Wang YH; Kuo WY; Li YH
    PLoS One; 2018; 13(6):e0199532. PubMed ID: 29933395
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Effects of hypoxia inducible factor-2α on promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation].
    Wu L; Zhou W; Zhou S; Liu C; Li S
    Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):112-7. PubMed ID: 25880977
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Combination of in-situ hepatic split and portal ligation in patients with colorectal cancer and metastatic hepatic spread].
    Shchepotin IB; Kolesnik OO; Lukashenko AV; Burlaka AA; Pryĭmak VV; Hanich OV
    Klin Khir; 2014 Nov; (11):8-13. PubMed ID: 25675734
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.
    Cassidy J; Clarke S; Díaz-Rubio E; Scheithauer W; Figer A; Wong R; Koski S; Rittweger K; Gilberg F; Saltz L
    Br J Cancer; 2011 Jun; 105(1):58-64. PubMed ID: 21673685
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression.
    Quiles-Perez R; Muñoz-Gámez JA; Ruiz-Extremera A; O'Valle F; Sanjuán-Nuñez L; Martín-Alvarez AB; Martín-Oliva D; Caballero T; Muñoz de Rueda P; León J; Gonzalez R; Muntané J; Oliver FJ; Salmerón J
    Hepatology; 2010 Jan; 51(1):255-66. PubMed ID: 20034026
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels.
    Kobayashi M; Suzuki F; Akuta N; Suzuki Y; Sezaki H; Yatsuji H; Kawamura Y; Hosaka T; Kobayashi M; Arase Y; Ikeda K; Mineta R; Iwasaki S; Watahiki S; Miyakawa Y; Kumada H
    Scand J Gastroenterol; 2009; 44(8):975-83. PubMed ID: 19521923
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment.
    Pu CY; Lan VM; Lan CF; Lang HC
    Eur J Cancer Care (Engl); 2008 Jul; 17(4):340-9. PubMed ID: 18537814
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Management of liver hemangiomas according to size and symptoms.
    Erdogan D; Busch OR; van Delden OM; Bennink RJ; ten Kate FJ; Gouma DJ; van Gulik TM
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1953-8. PubMed ID: 17914976
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic significance of HIF-2alpha/epas1 expression in hepatocellular carcinoma.
    Bangoura G; Liu ZS; Qian Q; Jiang CQ; Yang GF; Jing S
    World J Gastroenterol; 2007 Jun; 13(23):3176-82. PubMed ID: 17589895
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.